Selected research
Market Outlook & Growth Opportunities
Global Carotid Artery Shunt Market Outlook and Growth Opportunities 2026
Market perspective
The global Carotid Artery Shunt market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Carotid Artery Shunt is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Carotid Artery Shunt is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Carotid Artery Shunt is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Carotid Artery Shunt market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Carotid Artery Shunt market include Cardinal Health, LeMaitre Vascular, Integra LifeSciences, Edwards Lifesciences and BD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Carotid Artery Shunt market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Carotid Artery Shunt and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Carotid Artery Shunt sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Carotid Artery Shunt market size, projected growth trends, production technologies, key applications, and end-use industries.
Carotid Artery Shunt Segment by Company
Cardinal Health
LeMaitre Vascular
Integra LifeSciences
Edwards Lifesciences
BD
Carotid Artery Shunt Segment by Type
11F
Type II
Carotid Artery Shunt Segment by Application
Hospital
Clinic
Others
Carotid Artery Shunt Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Carotid Artery Shunt status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Carotid Artery Shunt market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Carotid Artery Shunt significant trends, drivers, influence factors in global and regions.
6. To analyze Carotid Artery Shunt competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carotid Artery Shunt market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Carotid Artery Shunt and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carotid Artery Shunt.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Carotid Artery Shunt market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Carotid Artery Shunt industry.
Chapter 3: Detailed analysis of Carotid Artery Shunt manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Carotid Artery Shunt in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Carotid Artery Shunt in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 11F
- Type II
Applications
- Hospital
- Clinic
- Others
Companies covered
- Cardinal Health
- LeMaitre Vascular
- Integra LifeSciences
- Edwards Lifesciences
- BD
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Carotid Artery Shunt Sales Value (2021-2032)
- 1.2.2 Global Carotid Artery Shunt Sales Volume (2021-2032)
- 1.2.3 Global Carotid Artery Shunt Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Carotid Artery Shunt Market Dynamics
- 2.1 Carotid Artery Shunt Industry Trends
- 2.2 Carotid Artery Shunt Industry Drivers
- 2.3 Carotid Artery Shunt Industry Opportunities and Challenges
- 2.4 Carotid Artery Shunt Industry Restraints
3 Carotid Artery Shunt Market by Company
- 3.1 Global Carotid Artery Shunt Company Revenue Ranking in 2025
- 3.2 Global Carotid Artery Shunt Revenue by Company (2021-2026)
- 3.3 Global Carotid Artery Shunt Sales Volume by Company (2021-2026)
- 3.4 Global Carotid Artery Shunt Average Price by Company (2021-2026)
- 3.5 Global Carotid Artery Shunt Company Ranking (2024-2026)
- 3.6 Global Carotid Artery Shunt Company Manufacturing Base and Headquarters
- 3.7 Global Carotid Artery Shunt Company Product Type and Application
- 3.8 Global Carotid Artery Shunt Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Carotid Artery Shunt Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Carotid Artery Shunt Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Carotid Artery Shunt Market by Type
- 4.1 Carotid Artery Shunt Type Introduction
- 4.1.1 11F
- 4.1.2
- 4.2 Global Carotid Artery Shunt Sales Volume by Type
- 4.2.1 Global Carotid Artery Shunt Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Carotid Artery Shunt Sales Volume by Type (2021-2032)
- 4.2.3 Global Carotid Artery Shunt Sales Volume Share by Type (2021-2032)
- 4.3 Global Carotid Artery Shunt Sales Value by Type
- 4.3.1 Global Carotid Artery Shunt Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Carotid Artery Shunt Sales Value by Type (2021-2032)
- 4.3.3 Global Carotid Artery Shunt Sales Value Share by Type (2021-2032)
5 Carotid Artery Shunt Market by Application
- 5.1 Carotid Artery Shunt Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Carotid Artery Shunt Sales Volume by Application
- 5.2.1 Global Carotid Artery Shunt Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Carotid Artery Shunt Sales Volume by Application (2021-2032)
- 5.2.3 Global Carotid Artery Shunt Sales Volume Share by Application (2021-2032)
- 5.3 Global Carotid Artery Shunt Sales Value by Application
- 5.3.1 Global Carotid Artery Shunt Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Carotid Artery Shunt Sales Value by Application (2021-2032)
- 5.3.3 Global Carotid Artery Shunt Sales Value Share by Application (2021-2032)
6 Carotid Artery Shunt Regional Sales and Value Analysis
- 6.1 Global Carotid Artery Shunt Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Carotid Artery Shunt Sales by Region (2021-2032)
- 6.2.1 Global Carotid Artery Shunt Sales by Region: 2021-2026
- 6.2.2 Global Carotid Artery Shunt Sales by Region (2027-2032)
- 6.3 Global Carotid Artery Shunt Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Carotid Artery Shunt Sales Value by Region (2021-2032)
- 6.4.1 Global Carotid Artery Shunt Sales Value by Region: 2021-2026
- 6.4.2 Global Carotid Artery Shunt Sales Value by Region (2027-2032)
- 6.5 Global Carotid Artery Shunt Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Carotid Artery Shunt Sales Value (2021-2032)
- 6.6.2 North America Carotid Artery Shunt Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Carotid Artery Shunt Sales Value (2021-2032)
- 6.7.2 Europe Carotid Artery Shunt Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Carotid Artery Shunt Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Carotid Artery Shunt Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Carotid Artery Shunt Sales Value (2021-2032)
- 6.9.2 South America Carotid Artery Shunt Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Carotid Artery Shunt Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Carotid Artery Shunt Sales Value Share by Country, 2025 VS 2032
7 Carotid Artery Shunt Country-level Sales and Value Analysis
- 7.1 Global Carotid Artery Shunt Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Carotid Artery Shunt Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Carotid Artery Shunt Sales by Country (2021-2032)
- 7.3.1 Global Carotid Artery Shunt Sales by Country (2021-2026)
- 7.3.2 Global Carotid Artery Shunt Sales by Country (2027-2032)
- 7.4 Global Carotid Artery Shunt Sales Value by Country (2021-2032)
- 7.4.1 Global Carotid Artery Shunt Sales Value by Country (2021-2026)
- 7.4.2 Global Carotid Artery Shunt Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.9.2 France Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.16.2 China Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.19.2 India Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Carotid Artery Shunt Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Carotid Artery Shunt Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Carotid Artery Shunt Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Cardinal Health
- 8.1.1 Cardinal Health Company Information
- 8.1.2 Cardinal Health Business Overview
- 8.1.3 Cardinal Health Carotid Artery Shunt Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Cardinal Health Carotid Artery Shunt Product Portfolio
- 8.1.5 Cardinal Health Recent Developments
- 8.2 LeMaitre Vascular
- 8.2.1 LeMaitre Vascular Company Information
- 8.2.2 LeMaitre Vascular Business Overview
- 8.2.3 LeMaitre Vascular Carotid Artery Shunt Sales, Value and Gross Margin (2021-2026)
- 8.2.4 LeMaitre Vascular Carotid Artery Shunt Product Portfolio
- 8.2.5 LeMaitre Vascular Recent Developments
- 8.3 Integra LifeSciences
- 8.3.1 Integra LifeSciences Company Information
- 8.3.2 Integra LifeSciences Business Overview
- 8.3.3 Integra LifeSciences Carotid Artery Shunt Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Integra LifeSciences Carotid Artery Shunt Product Portfolio
- 8.3.5 Integra LifeSciences Recent Developments
- 8.4 Edwards Lifesciences
- 8.4.1 Edwards Lifesciences Company Information
- 8.4.2 Edwards Lifesciences Business Overview
- 8.4.3 Edwards Lifesciences Carotid Artery Shunt Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Edwards Lifesciences Carotid Artery Shunt Product Portfolio
- 8.4.5 Edwards Lifesciences Recent Developments
- 8.5 BD
- 8.5.1 BD Company Information
- 8.5.2 BD Business Overview
- 8.5.3 BD Carotid Artery Shunt Sales, Value and Gross Margin (2021-2026)
- 8.5.4 BD Carotid Artery Shunt Product Portfolio
- 8.5.5 BD Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Carotid Artery Shunt Value Chain Analysis
- 9.1.1 Carotid Artery Shunt Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Carotid Artery Shunt Sales Mode & Process
- 9.2 Carotid Artery Shunt Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Carotid Artery Shunt Distributors
- 9.2.3 Carotid Artery Shunt Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst